MedPath

Development for certificated medical markers using safe pigments in the human body

Phase 1
Conditions
Diseases for which extractions are performed, jaw deformities, jaw bone cysts, jaw bone tumors, oral
Registration Number
JPRN-jRCTs032230507
Lead Sponsor
MARUOKA Yutaka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
5
Inclusion Criteria

1)Patients undergoing surgery (diseases requiring tooth extraction, jaw deformities, jaw bone cysts, jaw bone tumors, oral mucosa tumors, jaw bone fractures) at the Department of Oral and Maxillofacial Surgery, Center Hospital of National Center for Global Health and Medicine.
2) Adult men and women over 18 years of age
3) Persons who can provide written consent
4) Patients who are able to comply with the protocol and receive medical examinations as specified in this protocol during participation in the study.

Exclusion Criteria

1) Patients who are deemed inappropriate by the physician in charge.
2) Patients who already have pigmentation on the area to be marked.
3) Patients who may be allergic to the ingredients (ink) of the research equipment (Vivomark), etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Writing ability, visibility, and stability of marking on the jawbone and oral mucosa of the research instrument (Vivomark)<br>Reason for setting: Because the ability to reliably and accurately mark the surgical site is considered an important factor related to the quality and prognosis of surgical procedures, we will evaluate the ease of marking, accuracy, and exudation of the research device on the jawbone and oral mucosa as the main evaluation items.
Secondary Outcome Measures
NameTimeMethod
Evaluate the safety of medical devices based on the following items<br>1. presence or absence, degree, frequency and extent of allergic reactions at the marking site<br>2) Effect on wound healing<br>Presence/absence, degree of persistence, frequency and extent of tattoo scars at the marking site<br>4. occurrence, frequency, and severity of other serious adverse events and defects
© Copyright 2025. All Rights Reserved by MedPath